Cargando…
Anti-platelet drugs attenuate the expansion of circulating CD14(high)CD16(+) monocytes under pro-inflammatory conditions
AIMS: Levels of circulating CD14(high)CD16(+) monocytes increase in atherosclerotic patients and are predictive of future cardiovascular events. Platelet activation has been identified as a crucial determinant in the acquisition of a CD16(+) phenotype by classical CD14(high)CD16(−) cells. We tested...
Autores principales: | Layne, Kerry, Di Giosia, Paolo, Ferro, Albert, Passacquale, Gabriella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909161/ https://www.ncbi.nlm.nih.gov/pubmed/27118470 http://dx.doi.org/10.1093/cvr/cvw089 |
Ejemplares similares
-
Monocyte-Platelet Interaction Induces a Pro-Inflammatory Phenotype in Circulating Monocytes
por: Passacquale, Gabriella, et al.
Publicado: (2011) -
The effect of aspirin on circulating netrin-1 levels in humans is dependent on the inflammatory status of the vascular endothelium
por: Layne, Kerry, et al.
Publicado: (2017) -
Activated Platelets Convert CD14(+)CD16(-) Into CD14(+)CD16(+) Monocytes With Enhanced FcγR-Mediated Phagocytosis and Skewed M2 Polarization
por: Lee, Su Jeong, et al.
Publicado: (2021) -
CD14+CD16+ and CD14+CD163+ monocyte subpopulations in kidney allograft transplantation
por: Sekerkova, Alena, et al.
Publicado: (2014) -
Changes in the Monocytic Subsets CD14(dim)CD16(+) and CD14(++)CD16(−) in Chronic Systolic Heart Failure Patients
por: Amir, Offer, et al.
Publicado: (2012)